Drawing for IHV-DC

USPTO serial 87481638

IHV-DC

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SULLIVAN, JOHN C
Law office
TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with IHV-DC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-cancer preparations; Biological preparations for the treatment of infectious diseases; Cell growth media for growing cells for medical or clinical use; Culture media for cultivating dendritic cells; Human vaccine preparations; Medicinal preparations for cancer and virus infection; Pharmaceutical preparations, namely, antivirals; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Antivirals; Biological preparations for the treatment of cancer; Cells for medical or clinical use; Clinical medical reagents for processing human whole blood and its components for use in blood transfusions stored in bags, bottles, syringes and other such containers used to store such substances in the medical field; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Vaccine preparations; VaccinesACTIVEMay 1, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Aug 29, 2018MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 29, 2018ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 29, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 29, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 29, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 29, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 29, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 25, 2018ALIEASSIGNED TO LIE—
Jan 12, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 8, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2017DOCKASSIGNED TO EXAMINER—
Jun 15, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 12, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance